Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

JAK inhibitors show promise in treating difficult skin diseases.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

ZD1839 can cause skin issues like acne and hair changes.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

New compounds may help treat prostate issues without affecting androgen receptors.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Compound 4 is a promising treatment for hair loss with low toxicity.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.